IBDEI2HI ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39673,1,3,0)
;;=3^Malig Neop Bronchus/Lung,Unspec Part
;;^UTILITY(U,$J,358.3,39673,1,4,0)
;;=4^C34.90
;;^UTILITY(U,$J,358.3,39673,2)
;;=^5000966
;;^UTILITY(U,$J,358.3,39674,0)
;;=C65.9^^152^2000^154
;;^UTILITY(U,$J,358.3,39674,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39674,1,3,0)
;;=3^Malig Neop Renal Pelvis,Unspec
;;^UTILITY(U,$J,358.3,39674,1,4,0)
;;=4^C65.9
;;^UTILITY(U,$J,358.3,39674,2)
;;=^5001253
;;^UTILITY(U,$J,358.3,39675,0)
;;=C50.912^^152^2000^135
;;^UTILITY(U,$J,358.3,39675,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39675,1,3,0)
;;=3^Malig Neop Left Female Breast,Unspec Site
;;^UTILITY(U,$J,358.3,39675,1,4,0)
;;=4^C50.912
;;^UTILITY(U,$J,358.3,39675,2)
;;=^5001196
;;^UTILITY(U,$J,358.3,39676,0)
;;=C50.911^^152^2000^157
;;^UTILITY(U,$J,358.3,39676,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39676,1,3,0)
;;=3^Malig Neop Right Female Breast,Unspec Site
;;^UTILITY(U,$J,358.3,39676,1,4,0)
;;=4^C50.911
;;^UTILITY(U,$J,358.3,39676,2)
;;=^5001195
;;^UTILITY(U,$J,358.3,39677,0)
;;=C50.919^^152^2000^127
;;^UTILITY(U,$J,358.3,39677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39677,1,3,0)
;;=3^Malig Neop Female Breast,Unspec Site
;;^UTILITY(U,$J,358.3,39677,1,4,0)
;;=4^C50.919
;;^UTILITY(U,$J,358.3,39677,2)
;;=^5001197
;;^UTILITY(U,$J,358.3,39678,0)
;;=C62.90^^152^2000^165
;;^UTILITY(U,$J,358.3,39678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39678,1,3,0)
;;=3^Malig Neop Testis,Unspec
;;^UTILITY(U,$J,358.3,39678,1,4,0)
;;=4^C62.90
;;^UTILITY(U,$J,358.3,39678,2)
;;=^5001236
;;^UTILITY(U,$J,358.3,39679,0)
;;=D03.9^^152^2000^170
;;^UTILITY(U,$J,358.3,39679,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39679,1,3,0)
;;=3^Melanoma in Situ,Unspec
;;^UTILITY(U,$J,358.3,39679,1,4,0)
;;=4^D03.9
;;^UTILITY(U,$J,358.3,39679,2)
;;=^5001908
;;^UTILITY(U,$J,358.3,39680,0)
;;=C45.0^^152^2000^171
;;^UTILITY(U,$J,358.3,39680,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39680,1,3,0)
;;=3^Mesothelioma of Pleura
;;^UTILITY(U,$J,358.3,39680,1,4,0)
;;=4^C45.0
;;^UTILITY(U,$J,358.3,39680,2)
;;=^5001095
;;^UTILITY(U,$J,358.3,39681,0)
;;=C90.01^^152^2000^173
;;^UTILITY(U,$J,358.3,39681,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39681,1,3,0)
;;=3^Multiple Myeloma,In Remission
;;^UTILITY(U,$J,358.3,39681,1,4,0)
;;=4^C90.01
;;^UTILITY(U,$J,358.3,39681,2)
;;=^267515
;;^UTILITY(U,$J,358.3,39682,0)
;;=C90.00^^152^2000^174
;;^UTILITY(U,$J,358.3,39682,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39682,1,3,0)
;;=3^Multiple Myeloma,Not in Remission
;;^UTILITY(U,$J,358.3,39682,1,4,0)
;;=4^C90.00
;;^UTILITY(U,$J,358.3,39682,2)
;;=^5001752
;;^UTILITY(U,$J,358.3,39683,0)
;;=C94.6^^152^2000^175
;;^UTILITY(U,$J,358.3,39683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39683,1,3,0)
;;=3^Myelodysplastic Disease NEC
;;^UTILITY(U,$J,358.3,39683,1,4,0)
;;=4^C94.6
;;^UTILITY(U,$J,358.3,39683,2)
;;=^5001846
;;^UTILITY(U,$J,358.3,39684,0)
;;=D61.82^^152^2000^176
;;^UTILITY(U,$J,358.3,39684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39684,1,3,0)
;;=3^Myelophthisis
;;^UTILITY(U,$J,358.3,39684,1,4,0)
;;=4^D61.82
;;^UTILITY(U,$J,358.3,39684,2)
;;=^334037
;;^UTILITY(U,$J,358.3,39685,0)
;;=D47.9^^152^2000^177
;;^UTILITY(U,$J,358.3,39685,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39685,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HI 3841 printed Dec 13, 2024@02:28:51 Page 2
IBDEI2HI ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39673,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,39673,1,3,0)
+4 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
+5 ;;^UTILITY(U,$J,358.3,39673,1,4,0)
+6 ;;=4^C34.90
+7 ;;^UTILITY(U,$J,358.3,39673,2)
+8 ;;=^5000966
+9 ;;^UTILITY(U,$J,358.3,39674,0)
+10 ;;=C65.9^^152^2000^154
+11 ;;^UTILITY(U,$J,358.3,39674,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,39674,1,3,0)
+14 ;;=3^Malig Neop Renal Pelvis,Unspec
+15 ;;^UTILITY(U,$J,358.3,39674,1,4,0)
+16 ;;=4^C65.9
+17 ;;^UTILITY(U,$J,358.3,39674,2)
+18 ;;=^5001253
+19 ;;^UTILITY(U,$J,358.3,39675,0)
+20 ;;=C50.912^^152^2000^135
+21 ;;^UTILITY(U,$J,358.3,39675,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,39675,1,3,0)
+24 ;;=3^Malig Neop Left Female Breast,Unspec Site
+25 ;;^UTILITY(U,$J,358.3,39675,1,4,0)
+26 ;;=4^C50.912
+27 ;;^UTILITY(U,$J,358.3,39675,2)
+28 ;;=^5001196
+29 ;;^UTILITY(U,$J,358.3,39676,0)
+30 ;;=C50.911^^152^2000^157
+31 ;;^UTILITY(U,$J,358.3,39676,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,39676,1,3,0)
+34 ;;=3^Malig Neop Right Female Breast,Unspec Site
+35 ;;^UTILITY(U,$J,358.3,39676,1,4,0)
+36 ;;=4^C50.911
+37 ;;^UTILITY(U,$J,358.3,39676,2)
+38 ;;=^5001195
+39 ;;^UTILITY(U,$J,358.3,39677,0)
+40 ;;=C50.919^^152^2000^127
+41 ;;^UTILITY(U,$J,358.3,39677,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,39677,1,3,0)
+44 ;;=3^Malig Neop Female Breast,Unspec Site
+45 ;;^UTILITY(U,$J,358.3,39677,1,4,0)
+46 ;;=4^C50.919
+47 ;;^UTILITY(U,$J,358.3,39677,2)
+48 ;;=^5001197
+49 ;;^UTILITY(U,$J,358.3,39678,0)
+50 ;;=C62.90^^152^2000^165
+51 ;;^UTILITY(U,$J,358.3,39678,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,39678,1,3,0)
+54 ;;=3^Malig Neop Testis,Unspec
+55 ;;^UTILITY(U,$J,358.3,39678,1,4,0)
+56 ;;=4^C62.90
+57 ;;^UTILITY(U,$J,358.3,39678,2)
+58 ;;=^5001236
+59 ;;^UTILITY(U,$J,358.3,39679,0)
+60 ;;=D03.9^^152^2000^170
+61 ;;^UTILITY(U,$J,358.3,39679,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,39679,1,3,0)
+64 ;;=3^Melanoma in Situ,Unspec
+65 ;;^UTILITY(U,$J,358.3,39679,1,4,0)
+66 ;;=4^D03.9
+67 ;;^UTILITY(U,$J,358.3,39679,2)
+68 ;;=^5001908
+69 ;;^UTILITY(U,$J,358.3,39680,0)
+70 ;;=C45.0^^152^2000^171
+71 ;;^UTILITY(U,$J,358.3,39680,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,39680,1,3,0)
+74 ;;=3^Mesothelioma of Pleura
+75 ;;^UTILITY(U,$J,358.3,39680,1,4,0)
+76 ;;=4^C45.0
+77 ;;^UTILITY(U,$J,358.3,39680,2)
+78 ;;=^5001095
+79 ;;^UTILITY(U,$J,358.3,39681,0)
+80 ;;=C90.01^^152^2000^173
+81 ;;^UTILITY(U,$J,358.3,39681,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,39681,1,3,0)
+84 ;;=3^Multiple Myeloma,In Remission
+85 ;;^UTILITY(U,$J,358.3,39681,1,4,0)
+86 ;;=4^C90.01
+87 ;;^UTILITY(U,$J,358.3,39681,2)
+88 ;;=^267515
+89 ;;^UTILITY(U,$J,358.3,39682,0)
+90 ;;=C90.00^^152^2000^174
+91 ;;^UTILITY(U,$J,358.3,39682,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,39682,1,3,0)
+94 ;;=3^Multiple Myeloma,Not in Remission
+95 ;;^UTILITY(U,$J,358.3,39682,1,4,0)
+96 ;;=4^C90.00
+97 ;;^UTILITY(U,$J,358.3,39682,2)
+98 ;;=^5001752
+99 ;;^UTILITY(U,$J,358.3,39683,0)
+100 ;;=C94.6^^152^2000^175
+101 ;;^UTILITY(U,$J,358.3,39683,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,39683,1,3,0)
+104 ;;=3^Myelodysplastic Disease NEC
+105 ;;^UTILITY(U,$J,358.3,39683,1,4,0)
+106 ;;=4^C94.6
+107 ;;^UTILITY(U,$J,358.3,39683,2)
+108 ;;=^5001846
+109 ;;^UTILITY(U,$J,358.3,39684,0)
+110 ;;=D61.82^^152^2000^176
+111 ;;^UTILITY(U,$J,358.3,39684,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,39684,1,3,0)
+114 ;;=3^Myelophthisis
+115 ;;^UTILITY(U,$J,358.3,39684,1,4,0)
+116 ;;=4^D61.82
+117 ;;^UTILITY(U,$J,358.3,39684,2)
+118 ;;=^334037
+119 ;;^UTILITY(U,$J,358.3,39685,0)
+120 ;;=D47.9^^152^2000^177
+121 ;;^UTILITY(U,$J,358.3,39685,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,39685,1,3,0)
+124 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
